Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Report

Global and Region Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：194
  • REPORT CODE：GMM972566
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugsmarket, defines the market attractiveness level of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs industry, describes the types of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market and the development prospects and opportunities of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market in Chapter 13.

    By Player:

    • Helsinn Group

    • Heron Therapeutics

    • Merck & Co Inc

    • Tesaro

    • GlaxoSmithKline Plc

    By Type:

    • Corticosteroids

    • Serotonin Antagonists

    • Dopamine Antagonists

    • NK-1 Inhibitors

    • Cannabinoids

    • Motion Sickness Treatments

    • Anti-anxiety Drugs

    • Other

    By End-User:

    • High Emetic Risk Intravenous Chemotherapy

    • Moderate Emetic Risk Intravenous Chemotherapy

    • Low and Minimal Emetic Risk Intravenous Chemotherapy

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 7.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 7.3 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 7.4 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 7.5 Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 7.6 India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 7.7 South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    8 Region and Country-wise Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    9 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Corticosteroids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global NK-1 Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Cannabinoids Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Motion Sickness Treatments Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Anti-anxiety Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global High Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Moderate Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global NK-1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Cannabinoids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Motion Sickness Treatments Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Anti-anxiety Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global High Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Moderate Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Competitive Analysis

    • 14.1 Helsinn Group

      • 14.1.1 Helsinn Group Company Details

      • 14.1.2 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • 14.2 Heron Therapeutics

      • 14.2.1 Heron Therapeutics Company Details

      • 14.2.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • 14.3 Merck & Co Inc

      • 14.3.1 Merck & Co Inc Company Details

      • 14.3.2 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • 14.4 Tesaro

      • 14.4.1 Tesaro Company Details

      • 14.4.2 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • 14.5 GlaxoSmithKline Plc

      • 14.5.1 GlaxoSmithKline Plc Company Details

      • 14.5.2 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs

    • Figure Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Picture

    • Table Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • Figure Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global NK-1 Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Cannabinoids Consumption and Growth Rate (2017-2022)

    • Figure Global Motion Sickness Treatments Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-anxiety Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global High Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Moderate Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK-1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cannabinoids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Motion Sickness Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-anxiety Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global High Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Moderate Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Helsinn Group (Foundation Year, Company Profile and etc.)

    • Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • Table Heron Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • Table Tesaro (Foundation Year, Company Profile and etc.)

    • Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US